Automatic detection of ICH & LVO on NCCT and CTA respectively, improving time to decision of viable treatment options.
Integrated mobile app for on-the-go access to imaging insights complete with agree/disagree capabilities and secure, HIPPA compliant, in-app communication.
Empowered by patented capabilities to accept or reject or adjust AI outputs. For an AI experience that is physician controlled, end to end.
Discover care team collaboration and an un-paralleled platform approach to AI with automatic detection of ICH and LVO on NCCT and CTA.
Suspected detection of five
intracranial hemorrhage subtypes
94% Accuracy |
91.4% Sensitivity |
97.5% Specificity* |
*Currently FDA & CE Marked.
AI powered LVO triage application
Validated LVO Detection
97.7% Accuracy |
97.9% Sensitivity |
97.6% Specificity* |
*Currently FDA & CE Marked.
Advanced dynamic perfusion technology produces meaningful color parametric maps that aid clinicians in the analysis of vascular supply to brain tissue.
Six Customizable Perfusion Maps
CBF CBV TTP |
|
*Currently FDA & CE Marked.
Faster, more consistent and more precise interpretation for the assessment of acute ischemic stroke.
*Currently only CE Marked.
Quickly access a full patient list on your mobile device
View, agree or disagree with image findings all while in the app
Touch controlled slice & phase scrolling, pan, zoom, switch to other images and window/level adjustment
HIPPA compliant communication, including instant messaging, group chat, and patient-level chat
Results are shared in your Intuition 3D client, the web-based Eureka AI Results Explorer, or the viewer of your choice including PACS and the EMR.
Harness the Ability to Accept, Reject, Relocate & Re-Run Algorithms
*All offerings are subject to availability and regulatory clearance, which may vary by country. Please verify product status with your local TeraRecon representative.
TeraRecon Headquarters
4309 Emperor Blvd, Suite 310
Durham, NC 27703
Tel: 650.372.1100
Fax: 650.372.1101
info@terarecon.com